Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.

Nature cancer·2026

Same author

Females experience a greater benefit from surgical resection in an immune-dependent manner in a preclinical glioblastoma model.

Neuro-oncology advances·2026

Same author

lncRNA in EGFR‑driven glioblastoma.

Nature cell biology·2026

Same author

Androgen loss accelerates brain tumour growth via HPA axis activation.

Nature·2026

Same author

Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling.

Circulation·2026

Same author

Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma.

Nature·2026

Search research articles

Related Experiment Video

Updated: May 22, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8⁺ T Cell Responses

Published on: May 6, 2019

Help! Male Hormones Dampen CD4+ T-cell Help in Cancer.

Juyeun Lee^1,2, Justin D Lathia^2,3,4,5,6

¹Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida.

Cancer Immunology Research

|May 21, 2026

Summary

This summary is machine-generated.

Sex hormones in males weaken CD4+ T-cell help, impairing antitumor immunity and promoting cancer progression. This highlights CD4+ T-cell help as a key factor in sex-biased cancer immunity and suggests new immunotherapy approaches.

More Related Videos

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8⁺ T Cells During Tumorigenesis

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 22, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8⁺ T Cell Responses

Published on: May 6, 2019

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8⁺ T Cells During Tumorigenesis

Published on: January 26, 2024

Area of Science:

Immunology
Cancer Biology
Endocrinology

Background:

Sex disparities in cancer outcomes are linked to differences in antitumor immunity.
The specific role of CD4+ T helper cells in sex-biased immunity is not well understood.

Purpose of the Study:

To investigate the role of CD4+ T helper cells in sex-biased antitumor immune responses.
To understand how sex hormones influence T-cell mediated cancer immunity.

Main Methods:

The study by Hunt and colleagues investigated the function of CD4+ T helper cells in male and female subjects.
Experimental models were used to assess the impact of sex hormones on immune responses against tumors.

Main Results:

Sex hormones were found to restrain CD4+ T-cell help in males.
This restraint weakens antitumor immune responses and promotes tumor progression in males.
CD4+ T-cell help was identified as a significant driver of sex-biased cancer immunity.

Conclusions:

CD4+ T-cell help is a critical, underappreciated factor in sex-biased cancer immunity.
Findings suggest potential for developing sex-informed cancer immunotherapy strategies.